Gyre Therapeutics Inc share price logo

Gyre Therapeutics Inc Share Price

NASDAQ: GYRE

Small Cap

$7.17

+0.23

(+3.31%)

as on

Gyre Therapeutics Inc Stock Performance

as on March 26, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $7.13
    $7.31
    downward going graph

    0.56%

    Downside

    1.95%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.11
    $11.78
    downward going graph

    14.78%

    Downside

    64.30%

    Upside

    downward going graph

Gyre Therapeutics Inc share price movements today

Previous Close
$6.94
Open
$7.31
Volume
477.8K
Day's Low - High
$7.13 - $7.31
52 Week Low - High
$6.11 - $11.78

Gyre Therapeutics Inc Historical Returns

1 Month Return
-19.77 %
3 Month Return
-3.48 %
1 Year Return
-26.87 %
3 Year Return
0 %
5 Year Return
0 %

Gyre Therapeutics Inc Stock Fundamentals & Key Indicators

Check Gyre Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$678.2M

EPS (TTM)

-0.32

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.66%

PE Ratio (TTM)

352

Industry PE ratio

0

PEG Ratio

0

EBITDA

14.0M

Revenue (TTM)

116.6M

Profit Margin

4.31%

Return On Equity TTM

8.21%

Gyre Therapeutics Inc Stock Valuation

Track how Gyre Therapeutics Inc P/E has moved over time to understand its valuation trends.

Gyre Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-13.94x)

June 30, 2024

Industry (0.00x)

March 25, 2026

Today (352.00x)

March 25, 2026

Highest (165.42x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 352.00x

Gyre Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gyre Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Gyre Therapeutics Inc image
Gyre Therapeutics Inc
SELL$678.2MNA3524.31%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$40.7B127.78%131.618.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$114.6B111.25%29.4232.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA111.235.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.9B60.03%17.7631.41%

Stock Returns calculator for Gyre Therapeutics Inc Stock including INR - Dollar returns

The Gyre Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Gyre Therapeutics Inc investment value today

Current value as on today

₹85,514

Returns

₹14,486

(-14.49%)

Returns from Gyre Therapeutics Inc Stock

₹24,447 (-24.45%)

Dollar Returns*

₹9,961 (+9.96%)

Analyst Recommendation on Gyre Therapeutics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Gyre Therapeutics Inc. Average target price of $18.67

Gyre Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Gyre Therapeutics Inc.

What analysts predicted

61.6%UPSIDE

Target Price

$18.67

Current Price

$7.17

Analyzed by

6 Analysts

Target

$18.67

Gyre Therapeutics Inc target price $18.67, a slight upside of 61.6% compared to current price of $7.17. According to 6 analysts rating.

Gyre Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Gyre Therapeutics Inc Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:100% versus previous 30 day period

Gyre Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
32
27
27
25
25
27
22
26
30
37
Gross Profit
30
25
26
24
24
26
21
25
28
35
Operating Income
12
-91
8
3
4
0
2
2
6
0
EBITDA
12
-4
8
3
4
1
2
2
8
0
Interest Expense
-
-
-
-
-
0
-
-
1
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
11
-100
12
6
3
0
4
2
7
0
Income Tax Expense
3
0
2
1
1
0
0
0
1
1
Net Income
3
-101
7
3
1
0
2
0
3
-1
Net Profit Margin
12.41%
-372.06%
27.72%
13.99%
4.41%
-0.36%
12.23%
1.65%
11.81%
-4.63%

Gyre Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
1
0
20
1
14
113
105
116
Gross Profit
-10
-11
-21
11
0
13
108
101
111
Operating Income
-20
-21
-33
-57
-83
9
-67
16
11
EBITDA
-16
-21
-33
-56
-87
10
20
17
14
Interest Expense
-
-
-
-
0
0
-
-
-
Depreciation
-
-
-
-
1
1
1
1
2
Income Before Tax
-16
-21
-30
-56
-87
9
-76
23
14
Income Tax Expense
3
0
3
0
0
5
8
5
-4
Net Income
-16
-21
-30
-55
-13
0
-92
12
5
Net Profit Margin
-4246.87%
-2117.98%
-500916.67%
-265.14%
-1198.32%
2.25%
-81.92%
11.43%
4.31%

Gyre Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-100
9
3
1
0
3
1
5
-2
Operating Cash Flow
3
2
-5
1
-2
0
2
4
-5
Investing Cash Flow
1
-7
-8
-2
-2
1
-3
-1
1
Financing Cash Flow
2
0
0
0
0
1
22
0
0
Change in Cash
7
-3
-13
0
-4
3
21
3
-3

Gyre Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-21
-30
-55
-56
-87
4
-85
17
9
Operating Cash Flow
-19
-28
-43
-55
-83
10
25
-3
1
Investing Cash Flow
-11
-71
27
9
48
-13
-19
-19
0
Financing Cash Flow
35
111
0
60
49
-45
2
2
24
Change in Cash
4
11
-15
14
13
-5
8
-21
25

Insights on Gyre Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 22.05M → 37.19M (in $), with an average increase of 16.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.9% return, outperforming this stock by 36.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, GYRE stock has moved down by -18.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 3.61M → -1.72M (in $), with an average decrease of 147.7% per quarter

About Gyre Therapeutics Inc

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.
OrganisationGyre Therapeutics Inc
Headquarters12770 High Bluff Drive, San Diego, CA, United States, 92130
CEOMr. Ping Zhang
E-voting on sharesClick here to vote

Key Management of Gyre Therapeutics Inc

Name

Title

Mr. Songjiang Ma

President & Director

Ms. Ruoyu Chen

Chief Financial Officer

Mr. Weiguo Ye

Chief Operating Officer

Mr. Ping Zhang

Interim CEO & Executive Chair

FAQs

What is Gyre Therapeutics Inc share price today?

Gyre Therapeutics Inc share price today is $7.17 as on at the close of the market. Gyre Therapeutics Inc share today touched a day high of $7.31 and a low of $7.13.

What is the 52 week high and 52 week low for Gyre Therapeutics Inc share?

Gyre Therapeutics Inc share touched a 52 week high of $11.78 on and a 52 week low of $6.11 on . Gyre Therapeutics Inc stock price today i.e. is closed at $7.17,which is 39.13% down from its 52 week high and 17.35% up from its 52 week low.

What is Gyre Therapeutics Inc's market capitalisation today?

Gyre Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Gyre Therapeutics Inc Stock (GYRE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Gyre Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gyre Therapeutics Inc Shares that will get you 0.2092 shares as per Gyre Therapeutics Inc share price of $7.17 per share as on March 26, 2026 at 1:29 am IST.

What is the minimum amount required to buy Gyre Therapeutics Inc Stock (GYRE) from India?

Indian investors can start investing in Gyre Therapeutics Inc (GYRE) shares with as little as ₹94.138 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹941.38 in Gyre Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Gyre Therapeutics Inc share’s latest price of $7.17 as on March 26, 2026 at 1:29 am IST, you will get 1.3947 shares of Gyre Therapeutics Inc. Learn more about fractional shares .